NCI Definition: A mature T-cell non-Hodgkin lymphoma, characterized by systemic disease and a polymorphous infiltrate involving lymph nodes and extranodal sites. The clinical course is typically aggressive. [1]

Angioimmunoblastic T-cell lymphomas most frequently harbor alterations in TET2, RHOA, DNMT3A, IDH2, and VAV1 [2].

Most Commonly Altered Genes in Angioimmunoblastic T-Cell Lymphoma

TET2 Mutation, TET2fs, RHOA Mutation, RHOA G17V, and TET2 Nonsense are the most common alterations in angioimmunoblastic T-cell lymphoma [2].

Top Alterations in Angioimmunoblastic T-Cell Lymphoma

Significant Genes in Angioimmunoblastic T-Cell Lymphoma


FLT3 +

IDH2 +

Disease Details

angioimmunoblastic T-cell lymphoma, Angioimmunoblastic Lymphadenopathy Type T-Cell Lymphoma, Angioimmunoblastic Lymphadenopathy with Dysproteinemia, AILD, AILT, Angioimmunoblastic Lymphadenopathy
Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
OncoTree Name
Angioimmunoblastic T-Cell Lymphoma
OncoTree Code


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.